DINESH

Nitta Gelatin India

Industry: Agribusiness
Latest CMP 1,679
Today's Change ▼ -1.42%
52-Week High / Low 2,024 | 919
Price Date: 30-Sep-2026
Recommendation Sell
Target Price 1,638
Expected Upside -1.2%
Forecast Horizon 2 Years
Historical CAGR Not Available
1,000 Invested —
Today's Value —
Investment Period < 5 Years

Stock Snapshot

Post Results Return
-11.1%
Negative Re-rating
1-Year Target Price
1,649
2-Year Target Price
1,638
52-Week High / Low
2,024 / 919
20-Day Return
+2.4%
Market Cap (Cr.)
1,524
Current PE
15.3
P/BV Ratio
3.0
Dividend Yield
—
Industry PE
22.1

Price Performance

Vista Outlook

Basis of our Recommendation

Nitta Gelatin India's recent management commentary highlights a strategic pivot towards high-value nutraceutical and pharmaceutical applications, which is crucial for revenue growth amid a challenging market environment. The company's focus on premium products and operational efficiency aims to mitigate raw material cost volatility and global trade barriers, supporting Vista's forecast of stable profit margins despite expected revenue contraction. The agribusiness sector's improving pricing power and resilience in the agrochemical segment provide a favorable backdrop, although inflationary pressures and reliance on imports remain significant headwinds. Over the next 12-24 months, Nitta Gelatin's commitment to R&D and capacity utilization will be key opportunities for growth, while the potential impact of low-cost competition and fluctuating input prices warrant close monitoring. Overall, Vista's outlook reflects cautious sentiment, with a target price indicating limited upside potential in the current valuation context

👍 Why We Like This Stock

  • Management's focus on high-value nutraceutical and pharmaceutical applications enhances revenue potential
  • Investment in R&D and operational efficiency aims to mitigate raw material cost volatility
  • Improving pricing power in the agribusiness sector supports margin stability

⚠ Things To Watch Out For

  • Expected revenue contraction poses challenges to overall financial performance
  • Inflationary pressures and reliance on imports could squeeze margins
  • Low-cost competition remains a structural risk to market share

Key Parameters

Balance Sheet Strength
Conservatively Financed
Market Share
Stable
Industry Outlook
Improving
Analyst View
Not Available
Dividend History
Irregular
FII Holdings
Stable

Financial Snapshot

View Technicals Analysis →
Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 533 527 588 572 580
Profit Before Tax (Cr.) 117 101 134 130 132
PBT Margin 21.9% 19.2% 22.8% 22.7% 22.8%
Net Profit (Cr.) 88 72 99 97 98
Earnings Per Share 95.5 79.4 108.6 106.6 108.1

Analyst Recommendations

No analyst recommendations available.

Consensus Recommendation ► None
Consensus Target —
Coverage 0 Analysts
Analysts' Viewpoint

Company Overview

Show Company Profile

Nitta Gelatin India Limited engages in the manufacture and sale of ossein, gelatin, and collagen peptide in India and internationally. It offers wellnex collagen peptides for collagen peptide absorption, diabetes management, bones and joints, and beauty products; gelatin for pharmaceutical and edible applications; and Di Calcium Phosphate for use in poultry feed. The company provides chitosan for food, pharmaceutical, textile, agriculture, water treatment, and cosmetics industries, as well as ossein. It also exports its products. The company was formerly known as Kerala Chemicals & Proteins Limited and changed its name to Nitta Gelatin India Limited in 2008. Nitta Gelatin India Limited was incorporated in 1975 and is based in Kochi, India.